ID   c4 (B13NBii1)
AC   CVCL_9085
SY   c4; B13NBii1
DR   CLO; CLO_0002124
DR   ATCC; CRL-2717
DR   Wikidata; Q54808176
RX   PubMed=6623311;
RX   PubMed=6896205;
CC   Selected for resistance to: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=6623311; DOI=10.1007/BF01543050;
RA   Hankinson O.;
RT   "Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants
RT   of mouse hepatoma line, Hepa-1, and assignment of recessive mutants to
RT   three complementation groups.";
RL   Somatic Cell Genet. 9:497-514(1983).
//
RX   PubMed=6896205; DOI=10.1016/S0021-9258(20)65155-9;
RA   Legraverend C., Hannah R.R., Eisen H.J., Owens I.S., Nebert D.W.,
RA   Hankinson O.;
RT   "Regulatory gene product of the Ah locus. Characterization of receptor
RT   mutants among mouse hepatoma clones.";
RL   J. Biol. Chem. 257:6402-6407(1982).
//